Skip to main content

Table 1 Characteristics of participants

From: Creative thinking and cognitive estimation in Parkinson’s disease

 

PD (n = 20)

HC (n = 21)

PD versus HC (p value)

Effect size, Cohen’s d

Women/Men

10/10

11/10

n.s

 

Age (years)

68.1 (9.9)

67.3 (7.3)

n.s

 

Education (years)

12.2 (2.9)

13.0 (3.0)

n.s

 

Total LEDD (mg)

570 (311)

 

UPDRS part III

18.1 (10.9)

 

Disease duration (years)

7.15 (5.5)

 

PANDA

23.93 (4.1)

25.1 (3.6)

n.s

0.30

BDI-II

9.4 (4.9)

5.8 (3.9)

0.014

0.81

RWT „M”a

53.7 (31.5)

55.9 (29.9)

n.s

0.07

RWT „G-R”a

48.3 (29.3)

58.9 (27.7)

n.s

0.37

RWT „Food items “a

45.8 (26.3)

66.8 (23.7)

0.01

0.84

RWT „Sports-Fruits “a

55.2 (23.4)

69.1 (24.3)

n.s

0.58

FWIT (interference)b

54.7 (8.4)

61.2 (10.6)

0.038

0.68

CVLT List A (total)a

15.5 (26.5)

28.3 (24.6)

n.s

0.50

CVLT List B (total)a

21.9 (21.5)

31.1 (27.7)

n.s

0.37

CVLT delayed free recalla

22.8 (28.6)

22.3 (21.6)

n.s

0.02

CVLT cued recalla

20.2 (23.8)

31.4 (22.9)

n.s

0.47

LPS 3a

73.6 (19.6)

64.9 (27.6)

n.s

0.36

LPS 4a

79.6 (17.8)

73.4 (23.5)

n.s

0.29

TAP alertness without warningc

337 (82)

285 (61)

0.03

0.72

TAP alertness with warningc

305 (74)

274 (55)

n.s

0.51

TAP Go/noGoc

464 (70)

428 (72)

n.s

0.50

TAP Go/noGo, #errorsd

1.4 (1.3)

2.1 (2.4)

n.s

0.014

  1. aBased on percentiles according to published norms
  2. bBased on T-values according to published norms
  3. cMilliseconds
  4. dKruskal–Wallis-test (effect size eta2)
  5. n.s. Non-significant